Park House Surgery W91028: UK Public Sector Contracts Won & Awards
SME·Prestatyn·Nationwide (UK)·Main market: Medical practice and related services
Find a Tender organisation id184781
Where they win
4 lot-level observations (4 awarded lots, 100%, plus 0 envelope awards without lot links; pending awards included) · top CPV classes
8512 Medical practice and related services4 observations · 100% · lots| Largest published awards | Authority | Awarded | Term | Published value |
|---|---|---|---|---|
| Local Enhanced Clinical Effectiveness Service W94609 | Betsi Cadwaladr University Health Board | — | — | £15,424 † |
| Local Enhanced Clinical Effectiveness Service W91028 | Betsi Cadwaladr University Health Board | — | 1 yrs | £15,424 † ≈ £15k/yr |
| Edoxaban Review Service W94005 | Betsi Cadwaladr University Health Board | — | — | £2,340 † |
| Edoxaban Review Service W91028 | Betsi Cadwaladr University Health Board | — | 6 mo | £2,340 † |
Where they deliver
ITL1 delivery regions on the notice · 2 of 2 awarded procedures publish one · a procedure with several regions counts in each
Who they sell to
Authorities named on this supplier’s published awards · ranked by distinct procedures · award records explode on framework and DPS panels
- Education 100% (4 awards)
| Authority | Procedures | Share | Award records | Last activity |
|---|---|---|---|---|
| Betsi Cadwaladr University Health Board | 2 | 100% | 4 | 18 Sept 2026 |
Share = of the 2 procedures with an award naming this supplier. Last activity = award date, or notice publication when no award date was published.
Contracts ending
Published end dates only · 2 of 4 awards carry one · not a retender forecast
| Contract | Ends | Published value |
|---|---|---|
| Edoxaban Review Service W91028 | 31 Jan 2027 | £2,340 |
| Local Enhanced Clinical Effectiveness Service W91028 | 31 Mar 2027 | £15,424 |
Recent awards
Latest 4 of 4 award records naming this supplier
| Award / procedure | Authority | Awarded | Award value |
|---|---|---|---|
| Edoxaban Review Service W94005 | Betsi Cadwaladr University Health Board | Not published | Not published |
| Edoxaban Review Service W91028 | Betsi Cadwaladr University Health Board | Not published | Not published |
| Local Enhanced Clinical Effectiveness Service W94609 | Betsi Cadwaladr University Health Board | Not published | Not published |
| Local Enhanced Clinical Effectiveness Service W91028 | Betsi Cadwaladr University Health Board | Not published | Not published |
Data coverage & method
- Source: Find a Tender OCDS award and contract releases. An award record is one award × this supplier; a procedure can carry many (panels, call-offs).
- Market observations are awarded lots, or one envelope award when the notice publishes no lot links. Region = delivery ITL1 on the notice, not the supplier’s registered address.
- Authority type: official OCDS UK contracting-authority type when the notice publishes one; otherwise a Tenderline name/id class; otherwise “not classified”. Purchasing hubs with no published type stay unclassified.
- Published value attributable to this supplier alone: £36k across single-supplier awards, framework / DPS ceilings excluded. Coverage is partial and the figure is not turnover, so it is not shown as a headline.
- Contract end dates: published on 2 of 4 awards; 2 end within 18 months.
- Never shown: contact details, reliability or payment scores, affiliations, predicted wins.